Consolidated Interim Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from Operating Activities
Net (Loss) Income	$ (1,209,698)	$ 2,145,049
Adjustments to Reconcile Net (Loss) Income to Net Cash (Used In) Provided by Operating Activities
Stock based compensation	381,314	85,000
Bad debt expense	50,000
Depreciation and amortization	13,528	6,519
Changes in Assets and Liabilities
Decrease (Increase) in accounts receivable	1,443,706	(660,436)
(Increase) in inventories	(90,212)	(50,189)
(Increase) in vendor deposits	(41,761)	(190,234)
(Increase) in prepaid expenses	(22,398)	(79,947)
Increase in income taxes payable		63,259
(Decrease) increase in accounts payable and accrued expenses	(152,864)	(63,670)
(Decrease) Increase in deferred revenue	(498,364)	809,556
Total Adjustments	1,082,949	(1,600,541)
Net Cash (Used in) Provided by Operating Activities	(126,749)	544,508
Cash Flows From Investing Activities
Purchase of machinery and equipment	(98,244)	(12,999)
Cash paid for patent costs	(55,814)
Net Cash Used in Investing Activities	(154,058)	(12,999)
Cash Flows From Financing Activities
Payments on capital leases	(4,331)
(Decrease) in liabilities subject to compromise		(531,511)
Loan from officer	4,225	117,987
Payments on loans payable	(37,500)	(83,000)
Proceeds for equity raise, net	4,889,091
Proceeds from payroll protection plan loan	296,827
Net Cash Provided by (Used In) Financing Activities	5,148,312	(496,524)
Net Increase in Cash and equivalents	4,867,505	34,985
Cash and equivalents at January 1,	1,029,936	793,766
Cash and equivalents at September 30,	5,897,441	828,751
Cash paid during the period for:
Interest	1,204	$ 9,146
Supplemental Non-Cash Items
Reclassification from liabilities to be settled in stock to additional paid in capital for shares granted during the period	$ 808,986